Fast, complete and persistent eradication of papilloma warts as additional activity of an anti-infective against RNA viruses (Meeting abstract).

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Fast, complete and persistent eradication of papilloma warts as additional activity of an anti-infective against RNA viruses (Meeting abstract).

Experientia; 50:A26 1994. Unique Identifier : AIDSLINE ICDB/95611721
Wirth-Bronkowska LE; Wirth UV; aiRVi-Institute, Hohenweg 7, CH-5426 Lengnau

Abstract: Originally an anti-infectious drug against RNA viruses (aiRVi) was developed. Two different entities such as a biological and a chemical activity unit are necessary for efficiency of aiRVi. This antiviral drug could be used for disinfection, prevention and local therapy of RNA virus infections. Model systems will be developed, such as disinfection for hepatitis A, prevention against HIV causing pandemics AIDS and local therapy against tumor RNA viruses. During test phase of aiRVi in compatibility studies, a volunteer asked to get treatment of a permanent papilloma wart, that had not been eradicated with standard medical techniques up to that moment. Four days after the last operative excision of this wart on the finger it was obvious that the virus was establishing a new wart in the center of the wound again. At this time point, aiRVi was applied twice a day on the wound for two days. During this short time period the developing new wart was completely eradicated and never returned again now up to 3 month. The whole therapeutic procedure is recorded on video 8 tape, such tapes function as optimal, handy and cheap audiovisual lab-journals, which can be used later as proof and for documentation. In conclusion, beside the high potential of aiRVi against RNA virus infections, it seems that aiRVi is effective for DNA virus infections as well. Thus it would be interesting to examine, if other DNA virus infections (eg herpes viruses) or other localized tumors (eg skin tumors) could be treated as well.

Keywords: Antiviral Agents/PHARMACOLOGY/*THERAPEUTIC USE Condylomata Acuminata/*DRUG THERAPY/VIROLOGY Human Papillomavirus, Human/*DRUG EFFECTS RNA Viruses/*DRUG EFFECTS ABSTRACT
951030
M95A0974

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .